Just had a long talk with Robert Farrell, CEO of Kalytera Therapeutics. Although the PPS has been beaten down, it sounds like there are a lot of upcoming catalyst, some he couldn't get into detail about, but it sounds like possibly some major new business developments and possible partnerships coming into play. Interim data could be out in the next few months.
IMHO I would not miss out on these cheap prices, in the next 6 months there will be a lot of news coming.
Just my opinion!
News 
Market Data 
Discover 
